Cargando…
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
PURPOSE: Despite recent advances in the treatment of ovarian cancer (OC), long-term remissions remain scarce. For a targeted approach, prognostic markers are indispensable for predicting survival and treatment response. Given their association with multiple hallmarks of cancer, histamine receptors (...
Autores principales: | Kraus, Fabian B. T., Topalov, Nicole E., Deuster, E., Hysenaj, I., Mayr, D., Chelariu-Raicu, A., Beyer, S., Kolben, T., Burges, A., Mahner, S., Trillsch, F., Jeschke, U., Czogalla, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129941/ https://www.ncbi.nlm.nih.gov/pubmed/35751684 http://dx.doi.org/10.1007/s00432-022-04114-x |
Ejemplares similares
-
The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
por: Deuster, Eileen, et al.
Publicado: (2021) -
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
por: Topalov, Nicole Elisabeth, et al.
Publicado: (2021) -
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023) -
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022) -
Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
por: Deuster, Eileen, et al.
Publicado: (2019)